Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA5203581
Max Phase: Preclinical
Molecular Formula: C53H81N11O14S2
Molecular Weight: 1160.43
Associated Items:
ID: ALA5203581
Max Phase: Preclinical
Molecular Formula: C53H81N11O14S2
Molecular Weight: 1160.43
Associated Items:
Canonical SMILES: CC[C@H](C)[C@H](N)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCSC)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCSC)C(N)=O)C(C)C
Standard InChI: InChI=1S/C53H81N11O14S2/c1-9-29(6)43(55)52(77)62-40(26-42(68)69)51(76)59-36(22-27(2)3)47(72)61-39(25-41(54)67)50(75)60-37(23-30-10-14-32(65)15-11-30)49(74)58-35(19-21-80-8)46(71)64-44(28(4)5)53(78)63-38(24-31-12-16-33(66)17-13-31)48(73)57-34(45(56)70)18-20-79-7/h10-17,27-29,34-40,43-44,65-66H,9,18-26,55H2,1-8H3,(H2,54,67)(H2,56,70)(H,57,73)(H,58,74)(H,59,76)(H,60,75)(H,61,72)(H,62,77)(H,63,78)(H,64,71)(H,68,69)/t29-,34-,35-,36-,37-,38-,39-,40-,43-,44-/m0/s1
Standard InChI Key: RYAYTWNQFRWAKR-RKMJNRQDSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 1160.43 | Molecular Weight (Monoisotopic): 1159.5406 | AlogP: | #Rotatable Bonds: |
Polar Surface Area: | Molecular Species: | HBA: | HBD: |
#RO5 Violations: | HBA (Lipinski): | HBD (Lipinski): | #RO5 Violations (Lipinski): |
CX Acidic pKa: | CX Basic pKa: | CX LogP: | CX LogD: |
Aromatic Rings: | Heavy Atoms: | QED Weighted: | Np Likeness Score: |
1. Yoshida J, Takayama K, Kawada M.. (2022) Short peptides derived from hGAPDH exhibit anti-cancer activity., 71 [PMID:35964520] [10.1016/j.bmc.2022.116953] |
Source(1):